Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Covington
Cipla
Julphar
Argus Health
Express Scripts
Federal Trade Commission
US Department of Justice
Johnson and Johnson

Generated: May 24, 2018

DrugPatentWatch Database Preview

CEFAZOLIN IN PLASTIC CONTAINER Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Cefazolin In Plastic Container, and when can generic versions of Cefazolin In Plastic Container launch?

Cefazolin In Plastic Container is a drug marketed by Baxter Hlthcare Corp and is included in one NDA.

The generic ingredient in CEFAZOLIN IN PLASTIC CONTAINER is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
Summary for CEFAZOLIN IN PLASTIC CONTAINER
Drug patent expirations by year for CEFAZOLIN IN PLASTIC CONTAINER
Pharmacology for CEFAZOLIN IN PLASTIC CONTAINER
Medical Subject Heading (MeSH) Categories for CEFAZOLIN IN PLASTIC CONTAINER

US Patents and Regulatory Information for CEFAZOLIN IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare Corp CEFAZOLIN IN PLASTIC CONTAINER cefazolin sodium SOLUTION;INTRAVENOUS 207131-001 Aug 7, 2015 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Medtronic
Fuji
Teva
Dow
Cerilliant
Julphar
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.